Here are four recent news updates on key gastroenterology and endoscopy companies.
GI & Endoscopy
Intercept Pharmaceuticals has developed a new research initiative with the University of Pennsylvania's PennCHOP Microbiome Program, according to a Street Insider report.
In recognition of Colon Cancer Awareness Month this March, Silver Spring, Md.-based Capital Digestive Care launched a new informational website.
Jay Horton, MD, is chair of the division of digestive and liver diseases at UT Southwestern Medical Center in Dallas. He is also the Dr. Robert C. and Veronica Atkins Chair in Obesity & Diabetes Research and Distinguished Chair in…
Exalenz Bioscience is collaborating with the Acute Liver Failure Study Group.
GI Dynamics received the initial results from its pivotal clinical trial of the EndoBarrier therapy.
The Food and Drug Administration cleared five gastroenterology-related devices in February.
Ajay Jain, MD, received a grant from the National Institutes of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health.
The American Gastroenterology Association reported from the American Board of Internal Medicine GI Specialty Board Meeting that ABIM's efforts are focusing on "maintaining business as usual."
Mukund Venu, MD, is the medical director of GI operations and GI testing as well as an assistant professor of gastroenterology at Maywood, Ill.-based Loyola Medicine. He also served on the Patient Care Committee for the American College of Gastroenterology.
